BioCryst Pharmaceuticals is based in Durham, North Carolina. It has raised $350M in total funding. Latest round: Growth.
BioCryst Pharmaceuticals funding overview
BioCryst Pharmaceuticals is based in Durham, North Carolina. BioCryst Pharmaceuticals has raised $350M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in November 2021. The round record for BioCryst Pharmaceuticals runs through 2021; nothing later has been disclosed.
BioCryst Pharmaceuticals at a glance
Total raised
$350M
Latest round
Growth
Latest round date
November 2021
Headquarters
Durham, North Carolina
Frequently asked about BioCryst Pharmaceuticals funding
How much has BioCryst Pharmaceuticals raised?
BioCryst Pharmaceuticals has raised $350M in total disclosed funding across the rounds on record.
Who has invested in BioCryst Pharmaceuticals?
No investors are named on the public record for BioCryst Pharmaceuticals yet.
What was the latest BioCryst Pharmaceuticals funding round?
The most recent disclosed round is a Growth, announced in November 2021.
Where is BioCryst Pharmaceuticals based?
BioCryst Pharmaceuticals is based in Durham, North Carolina.
When did BioCryst Pharmaceuticals last raise?
The last disclosed BioCryst Pharmaceuticals round closed in November 2021 at Growth.
We update the BioCryst Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Durham and their backers are listed below.
Companies related to BioCryst Pharmaceuticals (18)
